10 Stocks Stole the Show, 5 Hit Historic Highs

Page 9 of 9

1. 89bio Inc. (NASDAQ:ETNB)

Shares of 89bio surged to a fresh record high on Thursday as investor funds poured into its stock following announcements that it was set to be acquired by Swiss company Roche for $3.5 billion.

At intra-day trading, 89bio Inc. (NASDAQ:ETNB) soared by as much as 86 percent to its highest 52-week price of $15.06, before trimming gains to end the day just up by 85.15 percent at $14.96 apiece.

In a statement, Roche said it entered into a definitive agreement to acquire 89bio Inc. (NASDAQ:ETNB) as it aims to advance innovative therapies in cardiovascular, renal, and metabolic diseases (CVRM), especially for patients affected by overweight, obesity, and related health challenges such as MASH.

Under the agreement, Roche will conduct a tender offer of all outstanding and issued shares of 89bio Inc. (NASDAQ:ETNB) at a price of $14.50 apiece.

The acquisition also includes a non-tradable CVR to receive certain milestone payments of up to an aggregate of $6.00 per share in cash, representing a total equity value of approximately $2.4 billion at closing, and a total deal value of up to $3.5 billion.

The price was said to be a premium of 52 percent over 89bio Inc.’s (NASDAQ:ETNB) 60-day volume weighted average price last September 17.

Roche said it expects to close the transaction in the fourth quarter of the year.

While we acknowledge the potential of ETNB to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than ETNB and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email below.

Page 9 of 9